Introduction
The Human CD197/CCR7 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the CCR7 receptor. This stable cell line is engineered to express high levels of the human CD197/CCR7 gene in HEK293T cells, making it an ideal model for investigating the function and regulation of this important chemokine receptor.
Structure of CD197/CCR7
The CD197/CCR7 receptor is a G protein-coupled receptor (GPCR) that is primarily expressed on the surface of immune cells, such as T cells and dendritic cells. It is composed of 7 transmembrane domains and has a molecular weight of approximately 40 kDa. The extracellular domain of CD197/CCR7 contains several conserved cysteine residues that are important for ligand binding, while the intracellular domain is responsible for signaling through G proteins.
Activity of CD197/CCR7
The primary function of CD197/CCR7 is to mediate the migration of immune cells to secondary lymphoid organs, where they can participate in immune responses. This is achieved through the binding of two chemokine ligands, CCL19 and CCL21, which are expressed in high levels in lymphoid tissues. Upon ligand binding, CD197/CCR7 activates G proteins, leading to the activation of downstream signaling pathways that regulate cell migration, adhesion, and survival.
In addition to its role in immune cell trafficking, CD197/CCR7 has also been implicated in other physiological processes, such as T cell development, activation, and differentiation. It has also been shown to play a role in the development and progression of various diseases, including cancer, autoimmune disorders, and infectious diseases.
Application of CD197/CCR7 HEK293T Stable Cell Line
The Human CD197/CCR7 HEK293T Stable Cell Line is a valuable tool for researchers studying the function and regulation of CD197/CCR7. This stable cell line provides a consistent and reliable source of CD197/CCR7 expression, allowing for the investigation of its role in various cellular processes and disease states.
One of the main applications of this stable cell line is in flow cytometry experiments. The high levels of CD197/CCR7 expression in these cells make them ideal for the detection and analysis of this receptor on the surface of immune cells. This can provide valuable insights into the expression patterns and activation status of CD197/CCR7 in different cell types and under different conditions.
Another potential application of the CD197/CCR7 HEK293T Stable Cell Line is in the development of therapeutics targeting this receptor. With its involvement in various diseases, CD197/CCR7 has emerged as a promising therapeutic target. By using this stable cell line, researchers can screen potential drug candidates and assess their effects on CD197/CCR7 signaling and function.
Conclusion
The Human CD197/CCR7 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the CCR7 receptor. Its high levels of CD197/CCR7 expression make it an ideal model for investigating the function and regulation of this important chemokine receptor. With its potential applications in flow cytometry and drug development, this stable cell line is a valuable resource for researchers interested in understanding the role of CD197/CCR7 in health and disease.
There are no reviews yet.